Prostate MRI: Multiparametric, Bi-parametric and What the Score Means
NICE now puts MRI before biopsy for suspected localised prostate cancer. What the scan involves, what bi-parametric drops, and what a PI-RADS or Likert score means.
A prostate MRI is a detailed scan of the prostate gland done before biopsy, not after it. NICE guideline NG131 says to offer multiparametric MRI as the first-line investigation for people with suspected clinically localised prostate cancer, and to report the result on a 5-point Likert scale. The scan tells the urologist whether to biopsy, and where.
This is general information, not medical advice. Anyone with urinary symptoms or a PSA result that worries them should speak to a GP.
Why the MRI now comes first
For decades the sequence ran the other way: a raised PSA led straight to a systematic biopsy, taking samples across the gland and hoping to hit anything significant. That approach missed some aggressive cancers and found a lot of small ones that would never have caused harm.
NICE NG131 changed the order. Its recommendations are to offer multiparametric MRI as the first-line investigation for suspected clinically localised prostate cancer, to report the result on a 5-point Likert scale, and to offer MRI-influenced biopsy where the Likert score is 3 or more. Where the score is 1 or 2, NICE says a biopsy can be considered for omission after a discussion of risks and benefits — including, in NICE's own framing, that a proportion of people with a low-risk MRI still have clinically significant cancer.
That last point matters and is often glossed over in private marketing. A reassuring MRI reduces the probability of significant disease. It does not reduce it to zero.
What "multiparametric" means
Multiparametric simply means the scan combines more than one type of image, each showing something different about the same tissue. Under the PI-RADS v2.1 standard, published by the PI-RADS Steering Committee with the American College of Radiology, an mpMRI includes three components:
- T2-weighted imaging, which shows the anatomy of the gland and the zones within it.
- Diffusion-weighted imaging with ADC maps, which measures how freely water molecules move — restricted movement is the single most important sign of significant cancer in the peripheral zone.
- Dynamic contrast-enhanced imaging, which follows an injected gadolinium contrast agent through the gland over time.
Under PI-RADS v2.1, contrast plays a supporting role rather than a leading one. Its main defined job is to upgrade an equivocal peripheral-zone lesion from category 3 to 4 when focal early enhancement is present.
Bi-parametric versus multiparametric, and the price gap
Bi-parametric MRI drops the contrast. You get T2 and diffusion-weighted imaging, no cannula, no gadolinium, and a shorter appointment. UK private providers price the two differently — one London centre published a bi-parametric prostate MRI at £495 against £595 for the multiparametric version when prices were checked in September 2026 — and the obvious question is whether the cheaper scan is the worse scan.
The best available answer is the PRIME trial, published in JAMA in 2025. It compared bi-parametric with multiparametric MRI for prostate cancer diagnosis and found bi-parametric non-inferior: clinically significant cancer was detected in 29% of men by both approaches, a difference of 0.4%, with 99% of scans judged adequate for diagnosis. Omitting contrast did not change biopsy recommendations or meaningfully alter treatment decisions.
That is level 1 evidence for the biopsy-naive setting, which is where most self-paying men sit. It is not a blanket ruling. Contrast is still used where the diffusion images are degraded, where a man has had previous treatment or a previous negative biopsy, or where the radiologist wants it. If you book bi-parametric and the reporting radiologist decides contrast is needed, expect to be called back — and note that contrast typically adds around £125 to a UK private MRI.
How to read a PI-RADS score
PI-RADS and Likert are two scoring systems doing the same job. PI-RADS is the international standard with defined imaging criteria; Likert is the scale NICE specifies for UK reporting, and it allows the radiologist to factor in clinical information such as PSA. Both run 1 to 5, and both express likelihood, not diagnosis.
| Score | PI-RADS v2.1 wording | What it broadly signals |
|---|---|---|
| 1 | Very low | Clinically significant cancer is highly unlikely |
| 2 | Low | Unlikely |
| 3 | Intermediate | Equivocal — the score that needs more information |
| 4 | High | Likely |
| 5 | Very high | Highly likely, and may show extraprostatic extension |
Under PI-RADS v2.1, the jump from 4 to 5 in the peripheral zone is largely about size: marked diffusion restriction under 1.5cm scores 4, and 1.5cm or larger, or with definite extraprostatic extension, scores 5.
A score is a radiologist's read of a picture. What happens next depends on your PSA, PSA density, examination findings, family history and your own preferences, weighed by a urologist. Do not book a private scan expecting the number to make the decision for you.
The screening context in the UK
There is no population prostate cancer screening programme in the UK, and as of 2026 there still isn't one. On 28 May 2026 the UK National Screening Committee recommended a targeted programme: a PSA test every two years for men aged 45 to 61 who have a BRCA2 gene change and a family history of breast, ovarian, pancreatic or prostate cancer. It explicitly recommended against screening all men in an age group, on the grounds that this would expose too many to overdiagnosis.
That is the backdrop to every private prostate MRI sold as a health check. Buying the scan without a clinical reason puts you outside what any UK body currently recommends.
What it costs privately, and what the price includes
Checking UK providers' published prices in September 2026, private prostate MRI ran from about £495 for bi-parametric and about £575 to £595 for multiparametric at independent London imaging centres, with specialist and upright providers quoting from around £735. Prices change, and these are market ranges rather than quotes.
Two cost traps are worth knowing. First, several large hospital groups publish no price at all and quote on enquiry, and where a hospital price is published it is often the hospital charge only, with the consultant's fee billed separately. Second, a scan without someone to interpret it is half a purchase — budget for a urology consultation, or have your referrer lined up before you book. Our MRI cost guide sets out the wider market, and how long scan results take covers reporting times.
When a symptom needs a doctor, not a booking
Being completely unable to pass urine is a medical emergency. Visible blood in the urine, new bone pain, or unexplained weight loss need a doctor's assessment promptly rather than a self-referred scan. If any of those apply, contact your GP or call 111.
Frequently asked questions
Do I need a referral for a private prostate MRI? Many independent imaging centres will accept a GP or consultant referral, and some accept self-referral. Because the result needs interpreting alongside PSA and examination, having a referring clinician is genuinely useful rather than a formality.
How long does the scan take? The NHS says an MRI usually takes between 15 minutes and an hour depending on the body part. Dropping contrast shortens the appointment, because there is no cannula and no post-contrast sequence.
Is there any preparation? It varies by provider. Some clinics ask you to avoid a heavy meal beforehand or to use a micro-enema to reduce rectal gas, because gas can degrade the diffusion images. Your clinic will tell you what it wants.
Can I have an MRI if I have a pacemaker or metal implants? That is a decision for the clinic's radiographer, not something to settle from an article. Bring the implant card, model details and any previous imaging so they can check the device against the scanner.
If you want to see which centres near you offer prostate MRI and what they charge, you can compare MRI providers on FindScan.
Common questions
Does a prostate MRI replace a biopsy?
Not always, but it changes who needs one. NICE guideline NG131 says biopsy should be offered where the MRI Likert score is 3 or more, and that omitting biopsy can be considered at a score of 1 or 2 after a discussion of the risks. The decision belongs to your urologist.
Is bi-parametric MRI worse than multiparametric?
The PRIME trial, published in JAMA in 2025, found bi-parametric MRI non-inferior to multiparametric for detecting clinically significant prostate cancer, with detection at 29% for both and a difference of 0.4%. Contrast is still used in some situations, and the reporting radiologist decides.
What does a PI-RADS 3 mean?
It means equivocal. PI-RADS v2.1 runs from 1, very low likelihood of clinically significant cancer, to 5, very high. A 3 sits in the middle and is the score where further information, such as PSA density or a repeat scan, most often changes the plan.
Should I have an MRI before or after a PSA test?
In UK practice the PSA result usually comes first and informs whether MRI is appropriate. Scores are interpreted alongside PSA, PSA density, examination and family history, which is why a scan report on its own is not a decision.
This article is general information, not medical advice, and it does not replace an assessment by a clinician. If you have symptoms that worry you, speak to your GP or call 111. In an emergency, call 999.